Development of Risk Prediction Model for Grade 2 or Higher Hypocalcemia in Patients With Bone Metastasis Treated With Denosumab Plus Cholecalciferol (Vitamin D3)/Calcium Supplement

Keisuke Ikegami, Masayuki Hashiguchi, Hayato Kizaki, Osamu Yasumuro, Ryohkan Funakoshi, Satoko Hori

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Development of Risk Prediction Model for Grade 2 or Higher Hypocalcemia in Patients With Bone Metastasis Treated With Denosumab Plus Cholecalciferol (Vitamin D3)/Calcium Supplement'. Together they form a unique fingerprint.

Medicine & Life Sciences